1 / 9

Functional impairment of bone marrow progenitor cells in diabetes mellitus

Functional impairment of bone marrow progenitor cells in diabetes mellitus. Nature Reviews Endocrinology 10, 379 (2014);. Introduction. While diabetes affects many aspects of human physiology, cardiovascular complications are the most common cause of morbidity and mortality in diabetic patients

baby
Download Presentation

Functional impairment of bone marrow progenitor cells in diabetes mellitus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Functional impairment of bone marrow progenitor cells in diabetes mellitus Nature Reviews Endocrinology 10, 379 (2014);

  2. Introduction • While diabetes affects many aspects of human physiology, cardiovascular complications are the most common cause of morbidity and mortality in diabetic patients • Specifically, diabetes causes dysfunction of the mature endothelium and impaired neovascularization in response to ischemia • It is evidenced by the reduced growth of collateral coronary vessels after acute myocardial infarction and the poor clinical outcomes associated with diabetic peripheral arterial disease

  3. Introduction • In the absence of diabetes, neovascularization in response to ischemic injury progresses partially through the recruitment of bone marrow-derived progenitor cells into ischemic tissues via the circulation, a process termed vasculogenesis • In this study, bone marrow-derived mesenchymal progenitor cells (MPCs) that have previously been shown to be important for new blood vessel formation were examined

  4. Research Design And Methods • Type 1 diabetes was induced in wild type mice with five consecutive daily injections of streptozotocin in sodium citrate • Two and four weeks after the last injection, blood glucose levels were assessed using a glucometer • Mice with capillary blood glucose levels <400 g/dL were excluded

  5. Results • The researchers had previously identified a subset of progenitor cells in the bone marrow that support vasculogenesis and mobilize into circulation in response to peripheral tissue ischaemia • Reduced levels of circulating progenitor cells have been reported in patients with diabetes mellitus • This suggests that deficiency of these cells could contribute to the pathogenesis of complications associated with this disease

  6. Results • The scientists demonstrated impaired vasculogenic function of diabetic bone-marrow-derived mesenchymal progenitor cells (BM-MPCs) in vivo and in vitro • An effect that was not reversed when glucose homeostasis levels in the mice were normalized, suggesting that these cells retained irreversible ‘diabetic memory’

  7. Results • Using a novel technique that combined single-cell transcriptional analysis and machine learning, the scientists also identified two distinct populations of BM-MPCs that were depleted in diabetic mice compared with wild-type mice • These subsets expressed high levels of vasculogenesis-related genes, which suggests that the depletion of these cells might be involved in impairment of neovascularization in diabetes mellitus

  8. Conclusion • The results suggest that dysfunction at the cellular level may compromise the mobilization and function of bone marrow-derived MPCs in diabetes • Also, the study demonstrates that these defects are irreversible • This suggests that cell-based therapeutics using autologous cells may be unlikely to succeed in correcting the effects of prolonged glucose exposure and impact the phenomenon of metabolic memory

  9. Conclusion • Additional studies of these distinct subpopulations of BM-MPCs will be required to prove the functional differences suggested by their gene expression • These data suggest that autologous stem cell-based therapies in diabetic patients may be limited by intrinsic deficits in important progenitor cell populations • Also, new strategies focusing on healthy (non-diabetic) progenitor cells may be required

More Related